Logo-aim
Arch Iran Med. 2021;24(11): 788-795. doi: 10.34172/aim.2021.118

Cohort Profile

Isfahan Thyroid Cohort Study (ITCS)

Samaneh Shahrokh Esfahani 1 ORCID, Aliye Tabatabaee 1 ORCID, Ashraf Aminorroaya 1 * ORCID, Masoud Amini 1 ORCID, Awat Feizi 2 ORCID, Mohsen Janghorbani 1 ORCID, Azamosadat Tabatabaei 1, Rokhsareh Meamar 3, Atoosa Adibi 1, Majid Abyar 1, Mozhgan Karimifar 1 ORCID, Raheleh Sajad 1 ORCID, Rezvan Salehidoost 1 ORCID, Elham Faghih Imani 1, Silva Hovsepian 1, Mehri Sirous 4, Sima Aminorroaya Yamini 5

Cited by CrossRef: 1

1- Ghaemmaghami Z, Firoozbakhsh P, Gholami D, Khodabandelu S, Baay M, Alemzadeh-Ansari M, Mohebbi B, Hosseini Z, Boudagh S, Pouraliakbar H, Pasebani Y, Rafati A, Khalilpour E, Khalili Y, Arabian M, Maleki M, Bakhshandeh H, Sadeghipour P. Increased prevalence of thyroid dysfunction in Tehran – HAMRAH study. BMC Endocr Disord. 2023;23(1) [Crossref]

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.